 |  |
OBAMANOMICS: John Harwood sits down with Barack Obama as he becomes the presumptive presidential nominee for the Democratic party. The economy is front and center in this year's race, so what's his plan? Also, tune in Tuesday night at 8p ET when CNBC details the economic positions of the top candidates in: "McCain Vs. Obama: A Your Money, Your Vote Special."
| TRADING OFF THE ADA: Mike Huckman is live from the American Diabetes Association Meeting in San Francisco where Eli Lilly, Amylin Pharmaceuticals and Alkermes will be presenting new test results on a once-a-week injectable version of the diabetes drug Byetta. Many analysts believe the product could become a multi-billion-dollar blockbuster. And some analysts say the one to watch on Tuesday morning could be a diabetes/obesity drug in late-stage development at a small biotech, Vivus.
| WHAT'S NEW AT HP: Jim Goldman exclusively interviews Todd Bradley, Hewlett-Packard's second in command who runs the $39 billion PC division, and previews the company's latest offerings. It's expected to be a big group of new products -- the largest since CEO Mark Hurd took over -- and should have an impact on the company's shares, and could affect Dell shares as well.
| MANAGING $26B: She's the woman at the helm of the nutmeg state's $26 billion employee pension fund. Connecticut Treasurer Denise Nappier sits down with Bertha Coombs to discuss why she hasn't invested in the hedge fund industry... yet. Nappier shares her alternative asset strategy and explains why she thinks institutional investors shouldn't be blamed for the run up in commodities prices.
| | | |
No comments:
Post a Comment